Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thornton, M. H.
Right arrow Articles by DiZerega, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thornton, M. H.
Right arrow Articles by DiZerega, G. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 1480-1485, Copyright © 1998 by Oxford University Press


ARTICLES

Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open-label pilot study

MH Thornton, DB Johns, JD Campeau, F Hoehler and GS DiZerega
Livingston Reproductive Biology Laboratory, University of Southern California School of Medicine, Santa Ana, USA.

The objective of this study was to assess the safety and to make a preliminary assessment of the efficacy of 0.5% ferric hyaluronate adhesion prevention gel in reducing adhesions in patients undergoing peritoneal cavity surgery by laparotomy, with a planned 'second-look' laparoscopy. The study was a randomized, open-label, placebo- controlled, parallel-group design in patients desirous of fertility at the Women's and Children's Hospital, Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, California. Female patients aged 24 to 41 years received 300 ml 0.5% ferric hyaluronate adhesion prevention gel or lactated Ringer's solution as an intraperitoneal instillate at the completion of the laparotomy procedure. At second-look laparoscopy 4-12 weeks after the laparotomy, the presence of adhesions was evaluated. Haematology and serum chemistry were determined throughout the study interval. All patients tolerated the procedures well and did not manifest any serious adverse events. At second-look laparoscopy, patients treated with 0.5% ferric hyaluronate adhesion prevention gel had significantly fewer adhesions than control patients. When adhesions did form, they were significantly less extensive and less severe in patients who received 0.5% ferric hyaluronate adhesion prevention gel. In conclusion, 0.5% ferric hyaluronate adhesion prevention gel was safe and highly efficacious in the reduction of the number, severity and extent of adhesions throughout the entire abdomen following peritoneal cavity surgery.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
C. Nappi, A. Di Spiezio Sardo, E. Greco, M. Guida, S. Bettocchi, and G. Bifulco
Prevention of adhesions in gynaecological endoscopy
Hum. Reprod. Update, July 1, 2007; 13(4): 379 - 394.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Acunzo, M. Guida, M. Pellicano, G. A. Tommaselli, A. Di Spiezio Sardo, G. Bifulco, D. Cirillo, A. Taylor, and C. Nappi
Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study
Hum. Reprod., September 1, 2003; 18(9): 1918 - 1921.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G.S. di Zerega, S.J.S. Verco, P. Young, M. Kettel, W. Kobak, D. Martin, J. Sanfilippo, E.M. Peers, A. Scrimgeour, and C.B. Brown
A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery
Hum. Reprod., April 1, 2002; 17(4): 1031 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Lundorff, H. van Geldorp, S. E. Tronstad, O. Lalos, B. Larsson, D. B. Johns, and G. S. diZerega
Reduction of post-surgical adhesions with ferric hyaluronate gel: a European study
Hum. Reprod., September 1, 2001; 16(9): 1982 - 1988.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Sawada, K. Tsukada, K. Hasegawa, Y. Ohashi, Y. Udagawa, and V. Gomel
Cross-linked hyaluronate hydrogel prevents adhesion formation and reformation in mouse uterine horn model
Hum. Reprod., February 1, 2001; 16(2): 353 - 356.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. J.S. Verco, E. M. Peers, C. B. Brown, K. E. Rodgers, N. Roda, and G. diZerega
Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies
Hum. Reprod., August 1, 2000; 15(8): 1764 - 1772.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Sawada, K. Hasegawa, K. Tsukada, and S. Kawakami
Adhesion preventive effect of hyaluronic acid after intraperitoneal surgery in mice
Hum. Reprod., June 1, 1999; 14(6): 1470 - 1472.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.